IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Opus Point Partners Management, LLC

Q3 2019 Holdings

Filed 2019-11-14 | 55 holdings | $3.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Charles RIV Labs Intl Inc(CRL)COM159864107$280.0K2,1128.3%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$432.0K12,00512.8%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$596.0K6,19017.7%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$654.0K9,70019.4%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$1.1M13,68432.6%
PreviousPage 2 of 2